Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Most Effective Methods of Birth Control and Biggest Brands In This Space

In this article, we shall discuss the 10 most effective methods of birth control and biggest brands in this space. To skip our detailed analysis of the contraceptives industry and the FemTech revolution in 2023, go directly and see 5 Most Effective Methods of Birth Control.

According to a market report by Precedence Research, the global contraceptives industry was valued at more than $16 billion in 2022 and is expected to surge to $27.72 billion by 2032, at an impressive CAGR of 5.70%. The skyrocketing number of unwanted pregnancies is a massive driver for the growing demand for contraceptive drugs, directly resulting in the global expansion of the birth control drugs market. According to March 2022 estimations by the UN Population Fund, almost half of all global pregnancies are unintended, totaling more than 121 million annually across the world, thereby exacerbating the global demand for effective methods of birth control. To read more on this, check out our article on 20 Countries with the Lowest Teenage Pregnancy Rates in the World. Furthermore, during the forecast period 2023-32, the approval, commercialization and development of innovative technology in the birth control industry is likely to prove to be a gamechanger for the industry. Some of the largest players in the contraceptives sector today are Merck and Co. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), and Church & Dwight Co. Ltd. (NYSE:CHD). 

The Roe v Wade Aftermath: An Analysis

According to a June 2023 report by Bloomberg, a significant driver for the rampant growth of the contraceptives industry in the United States is the overturning of the Roe v. Wade verdict by the United States Supreme Court. The verdict has prompted decisions and more serious conversations around stricter birth control methods, causing demand to skyrocket. According to the report, Nurx Therapeutics, a telemedicine company, claimed that they received a massive demand for emergency contraceptives post the reversal, amounting to a substantial increase of more than 300%.

However, the report goes on to detail that Big Pharma does not seem adequately geared to capitalize on the skyrocketing demand for the most effective methods for birth control and has marginally abandoned any innovation in the sector. Due to this, countless women have reported feeling that they are simply not receiving the best possible healthcare. According to a report by the Gates Foundation, merely 2% of drug companies’ annual revenue from contraceptives is diverted to research and development. In simpler words, Big Pharma is lagging behind in the innovation department and has not shown significant interest in introducing new products to the market.

During this time, the number of women expressing dissatisfaction with the existing birth control options is substantially increasing. The Bloomberg report postulates that younger women are less willing to engage with birth control which does not strive to meet their lifestyle and healthcare needs. Due to this, smaller companies are stepping in to capitalize on this untapped potential. This status quo is slowly leading to the rise of FemTech.

The “FemTech” Revolution: An Industry Overview

With smaller companies now investing more in women’s healthcare, better outcomes for women patients, consumers, investors, and other stakeholders across the value chain are predicted. The term “FemTech” encompasses a diverse variety of technology-enabled, consumer-centric products and solutions, geared towards enhancing healthcare for women across a number of specific sectors, including but not limited to maternal health, menstrual health, menopause and development of the most effective methods for birth control. In its 2022 report, McKinsey analyzed more than 750 FemTech companies, designated as tech-enabled solutions, addressing women’s health, excluding biopharma and incumbent medical devices. These companies also included some major players in the contraceptives industry like Merck and Co. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), and Church & Dwight Co. Ltd. (NYSE:CHD). Although FemTech innovation within these companies is still in its early stages, McKinsey outlines how FemTech dynamics are transforming rapidly with respect to public awareness, company formation, and funding. 

According to the analysis, the current market size for the FemTech industry is estimated to range from $500 million to more than $1 billion, depending on the scope, with projections forecasting potential for double-digit revenue growth. If one looks strictly at the digital health segment of the industry, FemTech companies are currently well placed to secure more than 4% of all digital health funding. However, when evaluated across the industry, concentration in the contraceptives area, maternal health patient support, and gynecological devices was more significant. In many instances, FemTech companies are filling gaps which haven’t been adequately addressed by large-scale biopharma and device companies, such as maternal health and contraception.

According to the report, FemTech companies have the potential to significantly disrupt conventional healthcare in a wide variety of ways. With initial breakthroughs now in the rearview mirror, the FemTech sector is looking to drastically invest in improving care delivery and developing the most effective methods of birth control. Virtual clinics such as Tia and brick-and-mortar clinics like Kindbody are enabling women to access healthcare in a more consumer-centric way. Additionally, the sector is also highly focused on improving diagnoses, with clinical diagnostic companies expanding on the scientific horizon to meet unaddressed medical requirements in areas like contraception, endometriosis, and preterm birth.

flocu/Shutterstock.com

Our Methodology

To compile our list of the 10 most effective methods of birth control and biggest brands in this space, we decided to use a variety of medical research journals and websites (1, 2, 3, 4, 5, 6). We evaluated the effectiveness of each birth control method based on their perfect use failure rates (10 points), efficacy over time (7 points), and overall user compliance (3 points). We then proceeded to score each method according to the aforementioned criteria and selected the 10 methods which scored the highest points. Subsequently, we ranked each method based on the total points it scored, from lowest to highest. Where there was a tie, we broke it based on its cumulative score in the perfect use failure rate and safety components respectively. With every entry on this list, we have also mentioned some of the biggest brands for each product.

To read more about the global contraceptives industry and its impact on population growth rates around the world, read our coverage of the 30 Countries With Highest Rates of Population Growth.

Most Effective Methods of Birth Control

10. Birth Control Patch

Average Score: 7

The birth control patch releases estrogen, which causes the cervical mucus to thicken and prevents ovulation. It is recommended that the user change the patch every week to increase its efficacy. To have effective results, the user must ensure that the birth control patch remains at its place, no antibiotics are taken, and that the user is not obese with respect to the BMI. The most prominent birth control patch brands are Xulane and Twirla. According to Planned Parenthood, these two are the only patches approved by the FDA in the United States. Ortho Evra is also one of the biggest brands in this space. To read more on the significance of the birth control patch, check out our article on the 25 Most Important Inventions of the 21st Century.

9. Progestin-only Pill

Average Score: 8

A progestin-only pill is more than 99% effective. Another name for this pill is minipill. The pill blocks the process of ovulation, thickens the cervical mucus, and thins the uterine lining. All these processes help in preventing pregnancy. It is highly advised to take the pill at the same time every day. The pill loses its efficacy if the user vomits within two hours of taking the pill, is taking a dose of antibiotics, or has a BMI that is considered obese. Some of the most prominent brands of the progestin-only pill include Camila, Errin, and Jencycla. 

8. Combination Pill

Average Score: 10

One of the most effective methods of birth control is the combination pill. Only about 9 in 100 users of the combination pill become pregnant, since its efficacy rate is less than 99% if used as recommended. The pill releases progestin and estrogen which prevent ovulation and thicken the cervical mucus. The thickening of the cervical mucus disallows sperms to reach the egg. To get an effective result, the user must take the pill at the same time every day. Additionally, the pill does not remain effective if the user vomits within two hours of taking the pill. There are multiple brands that sell combination pills; some of the largest brands include Yasmin, Microgynon 30, and Rigevidon. These brands are highly effective and easily accessible to users. 

7. Medroxyprogesterone Acetate Shot

Average Score: 11

A shot of medroxyprogesterone acetate is a hormonal method of birth control and is 99% effective, if the shot is taken on time. The user is recommended to take the shot every 12 weeks to prevent unwanted pregnancies. It injects progestin into the user’s body, which in turn helps in preventing ovulation and thickens the cervical mucus. By preventing ovulation, it impairs the ovaries from releasing the egg, and the thick cervical mucus does not let the sperms reach the uterus. This shot is provided only through prescription. The most common and trustworthy brand for a medroxyprogesterone acetate shot is the Depo-Provera Shot by Pfizer Inc. (NYSE:PFE). 

6. Vasectomy 

Average Score: 12

A vasectomy is a surgical procedure and by following this method, fewer than 1 in 100 users become pregnant. Vasectomy, or male sterilization, includes a procedure, in which the surgeon seals the tubes that carry sperm into the semen. This method permanently prevents pregnancy. However, for the first three months, the user is recommended to use back-up methods, like condoms, to negate any possibility of unintended pregnancy. A vasectomy is number 6 on our list of the 10 most effective methods for birth control

Click here to continue reading and see 5 Most Effective Methods of Birth Control

Suggested Articles:

Disclaimer: None. 10 Most Effective Methods of Birth Control and Biggest Brands In This Space is originally published on Insider Monkey.

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

  • It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
  • It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
  • It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

  • The AI infrastructure supercycle
  • The onshoring boom driven by Trump-era tariffs
  • A surge in U.S. LNG exports
  • And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…